REG - Intnl. Biotechnology - Dividend Declaration

International Biotechnology TrustAnnouncement

Yesterday 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250701:nRSA0665Pa&default-theme=true

RNS Number : 0665P  Intl. Biotechnology Trust PLC  01 July 2025

1 July 2025

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC

 

Second interim dividend for the year ending 31 August 2025

 

At the Annual General Meeting of International Biotechnology Trust plc (the
"Company") held on 9 December 2024, shareholders approved the Company's
dividend policy of making dividend payments, equivalent to 4% of the Company's
net asset value as at the last day of the preceding financial year (31 August
2024), through two equal semi-annual distributions.

 

The Directors have declared the payment of a second interim dividend of 16.17
pence per ordinary share for the year ending 31 August 2025.

 

In addition, the Company paid the first interim dividend of 15.56 pence per
ordinary share for the year ending 31 August 2025 on 24 January 2025.

 

As at 27 June 2025, the latest practicable date prior to publication of this
announcement, an annual dividend of 31.73 pence per share represents a yield
of 5.40% calculated with reference to the Company's closing share price of 588
pence on 27 June 2025.

 

 Ex-dividend date:    24 July 2025
 Record date:         25 July 2025
 Payment date:        22 August 2025
 Dividend per share:  16.17 pence

 

 

Enquiries:

Kerry Higgins

Schroder Investment Management Limited

Tel: 020 7658 6000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DIVFMMFTMTTJBPA